Nigeria’s Drug Regulatory Body Approves Herbal Medicine For COVID-19

Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) has approved a herbal drug that was produced by Afe Babalola University, Ado-Ekiti (ABUAD) for the treatment of COVID-19.

The founder of the University, also a senior advocate of Nigeria, Chief Afe Babalola disclosed this yesterday, in Ado-Ekiti, Ekiti State, at a ceremony commemorating the 12th anniversary of the establishment of ABUAD.

“I can confirm to you today that our herbal drug produced through extensive research by our team of researchers has healed about 19 patients who contracted covid-19 pandemic. They were healed perfectly less than five days of usage, which tells you the level of our research in ABUAD.”

Advertisement

Babalola noted that the research department of the university over the years has been churning out meaningful new discoveries aimed at solving the socio-economic problems of the country.

He said, “I am happy that I conceived this university twelve years ago and since then, we have been going from strength to strength, making exploits in all our endeavours. Our vision is to make this place a great institution in the university education in the country in teaching, research and community service

Author

  • Deborah Akwa

    Deborah Akwa is a content writer with over four years of experience creating brand stories, editorial content, and audience-focused articles on topics like health, lifestyle, and entertainment.

    When she isn't writing, she is behind the scenes managing editorial operations and helping the content team work better.

    She loves using words to connect brands with their audiences. Outside of work, she enjoys watching movies and engaging in thought-provoking conversations.

Share the Story
Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertisement

Keep Up to Date with the Most Important News

Weekly roundups. Sharp analysis. Zero noise.
The NewsCentral TV Newsletter delivers the headlines that matter—straight to your inbox, keeping you updated regularly.